Whitehead
‘Adopt NICE decisions’ committee told
November 27, 2012Sales and Marketing ABPI, Dorrell, NHS, NICE, Whitehead
ABPI chief executive Stephen Whitehead has again urged the NHS to adopt and use the drugs which NICE approves, and …
ABPI outlines vision for drug pricing reform
August 3, 2012Sales and Marketing ABPI, NICE, PPRS, VBP, Whitehead, value-based pricing
The ABPI has set out what it wants to see from the new drug pricing system in the UK. Negotiations …
ABPI to no longer ‘shy away’ from big issues
June 27, 2012Medical Communications, Sales and Marketing ABPI, Callaghan, NHS, VBP, Whitehead
The ABPI will actively seek to tackle tough issues like animal testing and clinical trial problems, as it looks to …
MP criticises drug shortages
June 25, 2012Sales and Marketing ABPI, Labour, NHS, Whitehead, shortages
A Labour MP has attacked major drug shortages in England that are seeing fewer drugs available to patients in the …
ABPI appoints new Innovation Board Chair
May 10, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Neil Weir, Whitehead
The senior vice president of discovery at UCB, Neil Weir, has been appointed as the next Chair of the ABPI …
Novartis right to challenge NHS on Avastin use – ABPI chief
April 27, 2012Sales and Marketing ABPI, Lucentis, Whitehead, avastin, wet AMD
The ABPI has declared its support for Novartis in its legal challenge against off-label prescribing in England.The pharma company is …
NHS must adopt new technologies faster, says minister
February 28, 2012Research and Development ABPI, NHS, Whitehead, Willetts, innovation
The NHS needs to speed up its adoption of new technology, according to universities and science minister David Willetts. Echoing …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
